BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Treatment
1541 results:

  • 1. DNMT1-targeting remodeling global DNA hypomethylation for enhanced tumor suppression and circumvented toxicity in oral squamous cell carcinoma.
    Liu Y; Sun Y; Yang J; Wu D; Yu S; Liu J; Hu T; Luo J; Zhou H
    Mol Cancer; 2024 May; 23(1):104. PubMed ID: 38755637
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Campothecin suppresses cell proliferation and migration in head and neck squamous cell carcinoma by blocking RAB27A-mediated phosphatidylinositol 3 kinase (PI3K)/protein kinase B (akt) pathway.
    Zhao Y; Wang Y; Zhao L; Qu L; Zheng JH
    J Physiol Pharmacol; 2024 Apr; 75(2):205-213. PubMed ID: 38736267
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. HMGA1 sensitizes esophageal squamous cell carcinoma to mTOR inhibitors through the ETS1-FKBP12 axis.
    Guo JR; He KY; Yuan JL; An W; Yin WT; Li QT; Lu LY; Yang JY; Liu MJ; Li YJ; Zhao Y; Yang Q; Lei XY; Gao F; Zhang L; Wu DH; Li JQ; Zhao ZL; Liu H; Zhu LJ; Xiang XY; Sun QH; Jian YP; Xu ZX
    Int J Biol Sci; 2024; 20(7):2640-2657. PubMed ID: 38725843
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The involvement of epidermal growth factor receptor/protein kinase B signaling in the tumor intrinsic PD-L1-induced malignant potential of oral squamous cell carcinoma.
    Sasabe E; Tomomura A; Yamamoto T
    J Oral Pathol Med; 2024 May; 53(5):310-320. PubMed ID: 38693616
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Fusobacterium periodonticum BCT protein targeting glucose metabolism to promote the epithelial-mesenchymal transition of esophageal cancer cells by lactic acid.
    Guo X; Wan P; Shen W; Sun M; Peng Z; Liao Y; Huang Y; Liu R
    J Transl Med; 2024 Apr; 22(1):401. PubMed ID: 38689341
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Biological functions of LncRNA SNHG14 in the development of thyroid cancer cells via targeting miR-206.
    Sang Y; Min R; Huang T; Zhang J
    Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):77-84. PubMed ID: 38678623
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Differences in the response of normal oral mucosa, oral leukoplakia, oral squamous cell carcinoma-derived mesenchymal stem cells, and epithelial cells to photodynamic therapy.
    Guo Q; Ji X; Zhang L; Liu X; Wang Y; Liu Z; Jin J; Han Y; Liu H
    J Photochem Photobiol B; 2024 Jun; 255():112907. PubMed ID: 38677259
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Dexrazoxane inhibits the growth of esophageal squamous cell carcinoma by attenuating SDCBP/MDA-9/syntenin-mediated EGFR-PI3K-akt pathway activation.
    Du R; Xiao N; Han L; Guo K; Li K; Chen Z; Zhang H; Zhou Z; Huang Y; Zhao X; Bian H
    Sci Rep; 2024 Apr; 14(1):9167. PubMed ID: 38649770
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Decision regret of cancer patients after radiotherapy: results from a cross-sectional observational study at a large tertiary cancer center in Germany.
    Rühle A; Wieland L; Hinz A; Mehnert-Theuerkauf A; Nicolay NH; Seidel C
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):167. PubMed ID: 38546873
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The emerging role and clinical significance of circRNAs in papillary thyroid cancer.
    Ma J; Xu J; Zhang X; Quan J
    Front Endocrinol (Lausanne); 2024; 15():1351776. PubMed ID: 38544689
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Microbiome Dysbiosis Is Associated with Castration Resistance and cancer Stemness in Metastatic Prostate cancer.
    Uzelac M; Xin R; Ongkeko WM
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542265
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. ADAM22 acts as a novel predictive biomarker for unfavorable prognosis and facilitates metastasis via PI3K/akt signaling pathway in nasopharyngeal carcinoma.
    Xu K; Jiang P; Chen Z; Gu X; Zhang T
    Pathol Res Pract; 2024 Apr; 256():155264. PubMed ID: 38518731
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Tyrosine phosphatase
    Chen X; Keller SJ; Hafner P; Alrawashdeh AY; Avery TY; Norona J; Zhou J; Ruess DA
    Front Immunol; 2024; 15():1340726. PubMed ID: 38504984
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Enhanced lipid biosynthesis in oral squamous cell carcinoma cancer-associated fibroblasts contributes to tumor progression: Role of IL8/akt/p-ACLY axis.
    Liu P; Wang Y; Li X; Liu Z; Sun Y; Liu H; Shao Z; Jiang E; Zhou X; Shang Z
    Cancer Sci; 2024 May; 115(5):1433-1445. PubMed ID: 38494608
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The antitumor effects of herbal medicine Triphala on oral cancer by inactivating PI3K/akt signaling pathway: based on the network pharmacology, molecular docking, in vitro and in vivo experimental validation.
    Hu S; Li S; Xu Y; Huang X; Mai Z; Chen Y; Xiao H; Ning W; Gaus S; Savkovic V; Lethaus B; Zimmerer R; Acharya A; Ziebolz D; Schmalz G; Huang S; Zhao J; Hu X
    Phytomedicine; 2024 Jun; 128():155488. PubMed ID: 38493718
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Cost-efficiency and budget-neutral expanded access modeling of the novel PD-1 inhibitor toripalimab versus pembrolizumab in recurrent or metastatic nasopharyngeal carcinoma.
    MacDonald K; Pondel M; Abraham I
    J Med Econ; 2024; 27(sup3):1-8. PubMed ID: 38488887
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. PHA-665752's Antigrowth and Proapoptotic Effects on HSC-3 Human Oral cancer Cells.
    Yadav AK; Wang S; Shin YM; Jang BC
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474118
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Role of deubiquitinase JOSD2 in the pathogenesis of esophageal squamous cell carcinoma.
    Wang WP; Shi D; Yun D; Hu J; Wang JF; Liu J; Yang YP; Li MR; Wang JF; Kong DL
    World J Gastroenterol; 2024 Feb; 30(6):565-578. PubMed ID: 38463028
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Potential targets of diosgenin for the treatment of oral squamous cell carcinoma and their bioinformatics and transcriptional profiling analyses.
    Xiao Y; Xu B; Li X; Ding T; Zhao W; Nie X; Mu J; Xiao Z; Wang Q; Ren Q; Zhang E
    Steroids; 2024 May; 205():109393. PubMed ID: 38458369
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. GSG2 promotes thyroid cancer via stabilizing AURKB and activating akt pathway.
    Zhang F; Huang C
    Aging (Albany NY); 2024 Mar; 16(6):5091-5107. PubMed ID: 38441546
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 78.